Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scrotal testosterone cream pharmacokinetics dose-finding study in healthy men
ACTRN12615000045516Phase 4Completed
- Sponsor
- Concord Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of testosterone and nandrolone, sponsored by Concord Hospital. Primary endpoint: Pharmacokinetics of testosterone after 3 single scrotal doses. Started Jun 2015; status: completed.
02
Drugs
testosteronenandrolone
Beyond the preview
Go deeper on ACTRN12615000045516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000045516.